We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: SeptiCyte RAPID test (Photo courtesy of Immunexpress, Inc.)

First One-Hour, Direct-from-Blood Sepsis Test Receives FDA Clearance

A fully automated diagnostic tool quantifies the relative expression levels of genes involved in a patient's immune response to infection to aid in a diagnosis in one hour for patients suspected of sepsis. More...
01 Dec 2021
Image: Three dimensional illustration of OPSCC showing cancer formation in the tissues of the oropharynx (Photo courtesy of Wikimedia Commons)

Liquid Biopsy Predicts Therapy Response in Patients with Late-Stage Throat Cancer

A liquid biopsy approach that measures levels of circulating tumor DNA (ctDNA) predicts therapy response in patients with stage III oropharyngeal squamous cell carcinoma (OPSCC) when used at an early point in the treatment procedure. More...
30 Nov 2021
Image: The miRNeasy Serum/Plasma Kit: For purification of cell-free total RNA, including miRNA, from human plasma and serum (Photo courtesy of Qiagen)

Serum MicroRNA Panel Predict P-Tau/Aβ42 in CSF in Alzheimer's Disease

Amyloid β (Aβ) and tau pathologies are classic characteristic features of Alzheimer’s disease (AD), and they are widely used as diagnostic biomarkers. AD pathology is characterized by the accumulation of amyloid-β (Aβ) plaques and tau neurofibrillary tangles in the brain. More...
29 Nov 2021
Image: A comparison of monocyte and neutrophil phenotype in grade III and grade IV gliomas (Photo courtesy of Jayashree V. Raghavan)

Biomarkers Predict Disease Progression for Patients with Late-stage Brain Tumors

A team of Indian researchers has identified potential blood-based biomarkers that predict disease progression and survival times for patients with late-stage glioma-type brain tumors. More...
29 Nov 2021
Image: Atellica Solution (Photo courtesy of Siemens Healthineers)

Siemens Introduces New Intelligent, Integrated IVD Solutions Virtually at EUROMEDLAB 2021

Siemens Healthineers (Erlangen, Germany) introduced new intelligent, integrated IVD solutions virtually at the XXIV IFCCEFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab Congress 2021). More...
29 Nov 2021
Illustration

Blood and Saliva Samples Can Be Used to Detect Genetic Markers for Liver Cancer

Doctors examining the markers of liver cancer have found that the disease can be recognized by RNA fragments in saliva and blood. More...
29 Nov 2021
Image: Bone marrow smear from a person with myelodysplastic syndrome showing aberrant morphology and maturation (dysmyelopoiesis), resulting in ineffective blood cell production (Photo courtesy of Melbourne Blood Specialists)

Next-Generation Sequencing Impacts All Aspects of Myelodysplastic Syndrome Care

Myelodysplastic Syndrome (MDS) is a type of blood cancer that affects the bone marrow. It causes low levels of one or more types of blood cells in the blood. MDS is more common in people aged over 70, but it can happen at any age. More...
25 Nov 2021
Visit expo >
Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Urine Chemistry Control
Dropper Urine Chemistry Control

In Other News



Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000 - 2025 Globetech Media.
All rights reserved.